K E Mulder - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Digestive Diseases and Sciences|October 28, 1998

Oral administration of rapamycin and cyclosporine differentially alter intestinal function in rabbitsV C Dias, K L Madsen, K E Mulder, et al.

Current Oncology (Toronto, Ont.)|January 5, 2017

Report from the 17th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Edmonton, Alberta; 11-12 September 2015K E Mulder, S Ahmed, J D Davies, et al.

Current Oncology (Toronto, Ont.)|June 19, 2014

One compared with two cycles of mitomycin C in chemoradiotherapy for anal cancer: analysis of outcomes and toxicityR Yeung, Y McConnell, G Roxin, et al.

Clinical Oncology (Royal College of Radiologists (Great Britain))|June 9, 2022

Does Loosening the Inclusion Criteria of the CROSS Trial Impact Outcomes in the Curative-Intent Trimodality Treatment of Oesophageal and Gastroesophageal Cancer Patients?A G Abraham, K Joseph, J L Spratlin, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Digestive Diseases and Sciences|October 28, 1998

Oral administration of rapamycin and cyclosporine differentially alter intestinal function in rabbitsV C Dias, K L Madsen, K E Mulder, et al.

Current Oncology (Toronto, Ont.)|January 5, 2017

Report from the 17th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Edmonton, Alberta; 11-12 September 2015K E Mulder, S Ahmed, J D Davies, et al.

Current Oncology (Toronto, Ont.)|June 19, 2014

One compared with two cycles of mitomycin C in chemoradiotherapy for anal cancer: analysis of outcomes and toxicityR Yeung, Y McConnell, G Roxin, et al.

Clinical Oncology (Royal College of Radiologists (Great Britain))|June 9, 2022

Does Loosening the Inclusion Criteria of the CROSS Trial Impact Outcomes in the Curative-Intent Trimodality Treatment of Oesophageal and Gastroesophageal Cancer Patients?A G Abraham, K Joseph, J L Spratlin, et al.

Pageof 1